CEGX

Cambridge Epigenetix (CEGX) aims to change the way medicine is practised by reducing several routine and important diagnostic screening tests to a simple blood draw using the power of epigenetics. Epigenetics is the way genes are switched on or off (“expressed”), without altering the genes themselves, due to the presence of small chemicals around DNA or its surrounding proteins.

Their disruptive discovery platform enables the identification of sensitive and disease-specific epigenetic marks from blood and tissue samples — enhancing human health through earlier diagnosis, improved patient stratification and the development of liquid biopsy-based tests.

Milestones
  • Partnered 2015
Team
  • Dr Jason Mellad
Partner
Sorry. This page is not yet translated.
Submit
Reset
Sort
Filter
  • Consumer
  • Enterprise
  • All
  • Devices
  • Financial
  • Gaming
  • Healthcare
  • Marketplace
  • Media
  • Productivity
  • Search
  • Social
  • All
  • Apps & Services
  • Data & Analytics
  • Dev Tools
  • Hardware
  • Healthcare
  • Infrastructure
  • Marketing
  • Networking
  • Security
  • Storage
The Dentmakers.

Since 1972, we have partnered early and at every stage of growth with the founders of companies that now have an aggregate, public market value of over $3.3 trillion. Meet the companies below.

Select Categories
Filter By Partner
Viewing Companies